{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:42:49Z","timestamp":1793216569401,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["OFLCG19May-0038"],"award-info":[{"award-number":["OFLCG19May-0038"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["NRF2019-NRF-ISF003-3127"],"award-info":[{"award-number":["NRF2019-NRF-ISF003-3127"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["I2101E0001"],"award-info":[{"award-number":["I2101E0001"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012415","name":"Biomedical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Preclinical models are often used for cancer studies and evaluation of novel therapeutics. The relevance of these models has vastly improved with mice bearing a human immune system, especially in the context of immunotherapy. Nonetheless, cancer is an age-related disease, and studies often overlook the effects of aging. Here we have established a humanized mouse model of human immune aging to investigate the role of this phenomenon on liver tumor dynamics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Multiple organs and tissues (blood, thymus, lung, liver, spleen and bone marrow) were harvested from NOD-<jats:italic>scid IL2r\u03b3<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> (NIKO) mice reconstituted with human immune cells, over a period of 60\u00a0weeks post-birth, for immune profiling. Young and aging immune cells were compared for transcriptomic changes and functional differences. Effect of immune aging was investigated in a liver cancer humanized mouse model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Focusing on the T cell population, which is central to cancer immunosurveillance and immunotherapy, we showed that the proportion of na\u00efve T cells declined while memory subsets and senescent-like cells increased with age. RNA-sequencing revealed that downregulated genes were related to immune responses and processes, and this was corroborated by reduced cytokine production in aging T cells. Finally, we showed faster liver tumor growth in aging than younger humanized mice, which could be attributed to specific pathways of aging T cell exhaustion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our work improves on existing humanized (immune) mouse model and highlights the importance of considering immune aging in liver cancer modeling.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12979-023-00374-4","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T02:01:34Z","timestamp":1695780094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Towards a better preclinical cancer model \u2013 human immune aging in humanized mice"],"prefix":"10.1186","volume":"20","author":[{"given":"Joel H. L.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Yi","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Xian","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Yee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"issue":"2","key":"374_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4331\/wjbc.v8.i2.129","volume":"8","author":"KI Isobe","year":"2017","unstructured":"Isobe KI, Nishio N, Hasegawa T. Immunological aspects of age-related diseases. World J Biol Chem. 2017;8(2):129\u201337.","journal-title":"World J Biol Chem"},{"issue":"4","key":"374_CR2","first-page":"552","volume":"76","author":"DL Palliyaguru","year":"2020","unstructured":"Palliyaguru DL, Vieira Ligo TC, Duregon E, di Germanio C, Alfaras I, Mitchell SJ, et al. Study of Longitudinal Aging in Mice: Presentation of Experimental Techniques. J Gerontology: Series A. 2020;76(4):552\u201360.","journal-title":"J Gerontology: Series A"},{"issue":"7","key":"374_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/CIRCRESAHA.118.312204","volume":"123","author":"AR Folgueras","year":"2018","unstructured":"Folgueras AR, Freitas-Rodr\u00edguez S, Velasco G, L\u00f3pez-Ot\u00edn C. Mouse models to disentangle the hallmarks of human aging. Circ Res. 2018;123(7):905\u201324.","journal-title":"Circ Res"},{"issue":"1","key":"374_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/0192623308329476","volume":"37","author":"RM Anderson","year":"2009","unstructured":"Anderson RM, Shanmuganayagam D, Weindruch R. Caloric restriction and aging: studies in mice and monkeys. Toxicol Pathol. 2009;37(1):47\u201351.","journal-title":"Toxicol Pathol"},{"issue":"23","key":"374_CR5","doi-asserted-by":"publisher","first-page":"14988","DOI":"10.1073\/pnas.232308999","volume":"99","author":"CK Lee","year":"2002","unstructured":"Lee CK, Allison DB, Brand J, Weindruch R, Prolla TA. Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc Natl Acad Sci U S A. 2002;99(23):14988\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"374_CR6","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.18632\/aging.100994","volume":"8","author":"SN Meydani","year":"2016","unstructured":"Meydani SN, Das SK, Pieper CF, Lewis MR, Klein S, Dixit VD, et al. Long-term moderate calorie restriction inhibits inflammation without impairing cell-mediated immunity: a randomized controlled trial in non-obese humans. Aging (Albany NY). 2016;8(7):1416\u201331.","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"374_CR7","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194\u2013217.","journal-title":"Cell"},{"issue":"6917","key":"374_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature"},{"issue":"1","key":"374_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","volume":"14","author":"S Tsalamandris","year":"2019","unstructured":"Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, et al. The role of inflammation in diabetes: current concepts and future perspectives. European Cardiol Rev. 2019;14(1):50\u20139.","journal-title":"European Cardiol Rev"},{"key":"374_CR10","doi-asserted-by":"crossref","unstructured":"Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022;23(2):905.","DOI":"10.3390\/ijms23020905"},{"key":"374_CR11","doi-asserted-by":"crossref","unstructured":"Puspitasari YM, Ministrini S, Schwarz L, Karch C, Liberale L, Camici GG. Modern concepts in cardiovascular disease: Inflamm-Aging.  Front Cell Dev Biol. 2022;10:882211.","DOI":"10.3389\/fcell.2022.882211"},{"issue":"5","key":"374_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","volume":"117","author":"JB Swann","year":"2007","unstructured":"Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest. 2007;117(5):1137\u201346.","journal-title":"J Clin Invest"},{"issue":"9","key":"374_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/14737140.2022.2098718","volume":"22","author":"JE Rodriguez","year":"2022","unstructured":"Rodriguez JE, Naigeon M, Goldschmidt V, Roulleaux Dugage M, Seknazi L, Danlos FX, et al. Immunosenescence, inflammaging, and cancer immunotherapy efficacy. Expert Rev Anticancer Ther. 2022;22(9):915\u201326.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"374_CR14","first-page":"170","volume":"2016","author":"RL Perlman","year":"2016","unstructured":"Perlman RL. Mouse models of human disease: An evolutionary perspective. Evol Med Public Health. 2016;2016(1):170\u20136.","journal-title":"Evol Med Public Health"},{"key":"374_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1023\/A:1006152915959","volume":"17","author":"RS Kerbel","year":"2004","unstructured":"Kerbel RS. What is the optimal rodent model for anti-tumor drug testing? Cancer Metastasis Rev. 2004;17:301\u20134.","journal-title":"Cancer Metastasis Rev"},{"issue":"18","key":"374_CR16","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1182\/blood-2017-04-778779","volume":"130","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Liu M, Chan XY, Tan SY, Subramaniam S, Fan Y, et al. Uncovering the mystery of opposite circadian rhythms between mouse and human leukocytes in humanized mice. Blood. 2017;130(18):1995\u20132005.","journal-title":"Blood"},{"issue":"4","key":"374_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.tips.2012.02.001","volume":"33","author":"DJ Adams","year":"2012","unstructured":"Adams DJ. The valley of death in anticancer drug development: a reassessment. Trends Pharmacol Sci. 2012;33(4):173\u201380.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"374_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40139-015-0086-y","volume":"3","author":"EW Uhl","year":"2015","unstructured":"Uhl EW, Warner NJ. Mouse models as predictors of human responses: evolutionary medicine. Current Pathobiology Reports. 2015;3(3):219\u201323.","journal-title":"Current Pathobiology Reports"},{"issue":"5","key":"374_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tips.2013.03.005","volume":"34","author":"G Peltz","year":"2013","unstructured":"Peltz G. Can \u201chumanized\u201d mice improve drug development in the 21st century? Trends Pharmacol Sci. 2013;34(5):255\u201360.","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"374_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nrmicro2911","volume":"10","author":"T Hatziioannou","year":"2012","unstructured":"Hatziioannou T, Evans DT. Animal models for HIV\/AIDS research. Nat Rev Microbiol. 2012;10(12):852\u201367.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"374_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"374_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12979-019-0165-8","volume":"16","author":"M Li","year":"2019","unstructured":"Li M, Yao D, Zeng X, Kasakovski D, Zhang Y, Chen S, et al. Age related human T cell subset evolution and senescence. Immunity Ageing. 2019;16(1):24.","journal-title":"Immunity Ageing"},{"issue":"5","key":"374_CR23","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.4049\/jimmunol.1400037","volume":"193","author":"SS Tay","year":"2014","unstructured":"Tay SS, Wong YC, Roediger B, Sierro F, Lu B, McDonald DM, et al. Intrahepatic activation of Naive CD4+ T cells by liver-Resident phagocytic cells. J Immunol. 2014;193(5):2087\u201395.","journal-title":"J Immunol"},{"issue":"1","key":"374_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-4933-5-6","volume":"5","author":"S Koch","year":"2008","unstructured":"Koch S, Larbi A, Derhovanessian E, \u00d6zcelik D, Naumova E, Pawelec G. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immunity & Ageing. 2008;5(1):6.","journal-title":"Immunity & Ageing"},{"issue":"8","key":"374_CR25","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/ijms18081742","volume":"18","author":"W Xu","year":"2017","unstructured":"Xu W, Larbi A. Markers of T cell senescence in humans. Int J Mol Sci. 2017;18(8):1742.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"374_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00262-016-1803-z","volume":"65","author":"H Kared","year":"2016","unstructured":"Kared H, Martelli S, Ng TP, Pender SLF, Larbi A. CD57 in human natural killer cells and T-lymphocytes. Cancer Immunol Immunother. 2016;65(4):441\u201352.","journal-title":"Cancer Immunol Immunother"},{"key":"374_CR27","doi-asserted-by":"publisher","first-page":"8694397","DOI":"10.1155\/2018\/8694397","volume":"2018","author":"JE Markel","year":"2018","unstructured":"Markel JE, Noore J, Emery EJ, Bobnar HJ, Kleinerman ES, Lindsey BA. Using the Spleen as an In Vivo systemic immune barometer alongside osteosarcoma disease progression and immunotherapy with \u03b1-PD-L1. Sarcoma. 2018;2018:8694397.","journal-title":"Sarcoma"},{"issue":"6","key":"374_CR28","doi-asserted-by":"publisher","first-page":"e1792-e","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015;6(6):e1792-e.","journal-title":"Cell Death Dis"},{"issue":"2","key":"374_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.imbio.2013.08.013","volume":"219","author":"DT Harris","year":"2014","unstructured":"Harris DT, Badowski M. Long term human reconstitution and immune aging in NOD-Rag (-)-\u03b3 chain (-) mice. Immunobiology. 2014;219(2):131\u20137.","journal-title":"Immunobiology"},{"issue":"1","key":"374_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12865-017-0209-9","volume":"18","author":"A Audig\u00e9","year":"2017","unstructured":"Audig\u00e9 A, Rochat M-A, Li D, Ivic S, Fahrny A, Muller CKS, et al. Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells. BMC Immunol. 2017;18(1):28.","journal-title":"BMC Immunol"},{"issue":"1","key":"374_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ni.3341","volume":"17","author":"EG Perdiguero","year":"2016","unstructured":"Perdiguero EG, Geissmann F. The development and maintenance of resident macrophages. Nat Immunol. 2016;17(1):2\u20138.","journal-title":"Nat Immunol"},{"issue":"51","key":"374_CR32","doi-asserted-by":"publisher","first-page":"21783","DOI":"10.1073\/pnas.0912274106","volume":"106","author":"Q Chen","year":"2009","unstructured":"Chen Q, Khoury M, Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci. 2009;106(51):21783\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"374_CR33","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s11357-012-9455-1","volume":"35","author":"I Alam","year":"2013","unstructured":"Alam I, Goldeck D, Larbi A, Pawelec G. Aging affects the proportions of T and B cells in a group of elderly men in a developing country\u2013a pilot study from Pakistan. Age (Dordr). 2013;35(5):1521\u201330.","journal-title":"Age (Dordr)"},{"issue":"7","key":"374_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nri2318","volume":"8","author":"J Nikolich-\u017dugich","year":"2008","unstructured":"Nikolich-\u017dugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol. 2008;8(7):512\u201322.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"374_CR35","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.4049\/jimmunol.1500046","volume":"194","author":"JJ Goronzy","year":"2015","unstructured":"Goronzy JJ, Fang F, Cavanagh MM, Qi Q, Weyand CM. Naive T cell maintenance and function in human aging. J Immunol. 2015;194(9):4073\u201380.","journal-title":"J Immunol"},{"key":"374_CR36","doi-asserted-by":"crossref","unstructured":"Tong Q-Y, Zhang J-C, Guo J-L, Li Y, Yao L-Y, Wang X, et al. Human Thymic involution and aging in humanized mice. Front Immunol. 2020;11:1399.","DOI":"10.3389\/fimmu.2020.01399"},{"key":"374_CR37","doi-asserted-by":"publisher","first-page":"103409","DOI":"10.1016\/j.ebiom.2021.103409","volume":"68","author":"J Zhang","year":"2021","unstructured":"Zhang J, He T, Xue L, Guo H. Senescent T cells: a potential biomarker and target for cancer therapy. EBioMedicine. 2021;68:103409.","journal-title":"EBioMedicine"},{"issue":"2","key":"374_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2020;20(2):89\u2013106.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"374_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/hiv.12081","volume":"15","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Moreno S, Fuentes-Ferrer M, S\u00e1nchez-Marcos C, \u00c1vila M, Sainz T, et al. The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery. HIV Med. 2014;15(1):40\u20139.","journal-title":"HIV Med"},{"issue":"2\u20133","key":"374_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0047-6374(97)00151-6","volume":"102","author":"A Wikby","year":"1998","unstructured":"Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev. 1998;102(2\u20133):187\u201398.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"374_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cmi.2010.56","volume":"8","author":"W Shah","year":"2011","unstructured":"Shah W, Yan X, Jing L, Zhou Y, Chen H, Wang Y. A reversed CD4\/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell Mol Immunol. 2011;8(1):59\u201366.","journal-title":"Cell Mol Immunol"},{"key":"374_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.humpath.2017.09.012","volume":"69","author":"K Wang","year":"2017","unstructured":"Wang K, Shen T, Siegal GP, Wei S. The CD4\/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Hum Pathol. 2017;69:110\u20137.","journal-title":"Hum Pathol"},{"key":"374_CR43","doi-asserted-by":"crossref","unstructured":"Ou Y, Deng Y, Wang H, Zhang Q, Luo H, Hu P. Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells. Front Med (Lausanne). 2021;8:649279.","DOI":"10.3389\/fmed.2021.649279"},{"issue":"14","key":"374_CR44","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.18632\/oncotarget.26659","volume":"10","author":"SA Greenberg","year":"2019","unstructured":"Greenberg SA, Kong SW, Thompson E, Gulla SV. Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models. Oncotarget. 2019;10(14):1399\u2013406.","journal-title":"Oncotarget"},{"key":"374_CR45","doi-asserted-by":"crossref","unstructured":"Haas L, Obenauf AC. Allies or Enemies\u2014The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment. Front Immunol. 2019;10:2746.","DOI":"10.3389\/fimmu.2019.02746"},{"issue":"2","key":"374_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359\u201367.","journal-title":"Br J Cancer"},{"issue":"1","key":"374_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","volume":"28","author":"RE Tay","year":"2021","unstructured":"Tay RE, Richardson EK, Toh HC. Revisiting the role of CD4+ T cells in cancer immunotherapy\u2014new insights into old paradigms. Cancer Gene Ther. 2021;28(1):5\u201317.","journal-title":"Cancer Gene Ther"},{"key":"374_CR48","doi-asserted-by":"crossref","unstructured":"Izgi H, Han D, Isildak U, Huang S, Kocabiyik E, Khaitovich P. et al. Inter-tissue convergence of gene expression during ageing suggests age-related loss of tissue and cellular identity. eLife. 2022;11:e68048.","DOI":"10.7554\/eLife.68048"},{"issue":"2","key":"374_CR49","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1365-2249.2000.01290.x","volume":"121","author":"M Saifuddin","year":"2000","unstructured":"Saifuddin M, Spear GT, Chang C, Roebuck KA. Expression of MHC class II in T cells is associated with increased HIV-1 expression. Clin Exp Immunol. 2000;121(2):324\u201331.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"374_CR50","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.humimm.2004.01.005","volume":"65","author":"TM Holling","year":"2004","unstructured":"Holling TM, Schooten E, van Den Elsen PJ. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum Immunol. 2004;65(4):282\u201390.","journal-title":"Hum Immunol"},{"issue":"3","key":"374_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165(3):535\u201350.","journal-title":"Cell"}],"container-title":["Immunity &amp; Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-023-00374-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-023-00374-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-023-00374-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T20:25:53Z","timestamp":1700425553000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-023-00374-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1186\/s12979-023-00374-4","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the A*STAR Institutional Review Board (IRB reference 2020\u2013040) and Institutional Animal Care and Use Committee (IACUC protocols #221686 and #221738).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Q.C. is the scientific founder of two biotech companies, Invivocue and Humlab global. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}